Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe
Open Access
- 1 January 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (1) , 71-76
- https://doi.org/10.1128/aac.49.1.71-76.2005
Abstract
Although quinolone resistance results mostly from chromosomal mutations, it may also be mediated by a plasmid-encoded qnr gene in members of the family Enterobacteriaceae . Thus, 297 nalidixic-acid resistant strains of 2,700 Escherichia coli strains that had been isolated at the Bicêtre Hospital (Le Kremlin-Bicêtre, France) in 2003 were screened for qnr by PCR. A single E. coli isolate that carried a ca. 180-kb conjugative plasmid encoding a qnr determinant was identified. It conferred low-level resistance to quinolones and was associated with a chromosomal mutation in subunit A of the topoisomerase II gene. The qnr gene was located on a sul1 -type class 1 integron just downstream of a conserved region (CR) element (CR1) comprising the Orf513 recombinase. Promoter sequences for qnr expression overlapped the extremity of CR1, indicating the role of CR1 in the expression of antibiotic resistance genes. This integron was different from other qnr -positive sul1 -type integrons identified in American and Chinese enterobacterial isolates. In addition, plasmid pQR1 carried another class 1 integron that was identical to In 53 from E. coli . The latter integron possessed a series of gene cassettes, including those coding for the extended-spectrum β-lactamase VEB-1, the rifampin ADP ribosyltransferase ARR-2, and several aminoglycoside resistance markers. This is the first report of plasmid-mediated quinolone resistance in Europe associated with an unknown level of plasmid-mediated multidrug resistance in Enterobacteriaceae .Keywords
This publication has 22 references indexed in Scilit:
- Prevalence of Plasmid-Mediated Quinolone ResistanceAntimicrobial Agents and Chemotherapy, 2003
- In34, a Complex In5 Family Class 1 Integron Containing orf513 and dfrA10Antimicrobial Agents and Chemotherapy, 2003
- Mechanism of plasmid-mediated quinolone resistanceProceedings of the National Academy of Sciences, 2002
- Intrinsic Resistance of Mycobacterium smegmatis to Fluoroquinolones May Be Influenced by New Pentapeptide Protein MfpAAntimicrobial Agents and Chemotherapy, 2001
- Emergence of Reduced Susceptibility and Resistance to Fluoroquinolones in Escherichia coli in Taiwan and Contributions of Distinct Selective PressuresAntimicrobial Agents and Chemotherapy, 2001
- Characterization of In53, a Class 1 Plasmid- and Composite Transposon-Located Integron ofEscherichia coliWhich Carries an Unusual Array of Gene CassettesJournal of Bacteriology, 2001
- Molecular Epidemiology of the Integron-Located VEB-1 Extended-Spectrum β-Lactamase in Nosocomial Enterobacterial Isolates in Bangkok, ThailandJournal of Clinical Microbiology, 2001
- Integron-located VEB-1 extended-spectrum beta-lactamase gene in a Proteus mirabilis clinical isolate from VietnamJournal of Antimicrobial Chemotherapy, 2000
- Molecular and Biochemical Characterization of VEB-1, a Novel Class A Extended-Spectrum β-Lactamase Encoded by an Escherichia coli Integron GeneAntimicrobial Agents and Chemotherapy, 1999
- Quinolone resistance from a transferable plasmidPublished by Elsevier ,1998